Back to search

Article

miR-708-5p Enhances Erlotinib/paclitaxel Efficacy and Overcomes Chemoresistance in Lung Cancer Cells

2020-10-15

Abstract excerpt

<title>Abstract</title> <p>BackgroundLung cancer is a collection of aggressive tumors generally not diagnosed until late-stage, resulting in high mortality rates. The vast majority of non-small cell lung cancer (NSCLC) patients undergo combinatory chemotherapeutic treatment, which initially reduces tumor growth, but frequently becomes ineffective due to toxicity and resistance. Researchers have identified multipl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec32a764-2c82-5a3e-9918-a7bfda46b949
DOI
10.21203/rs.3.rs-87253/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
miR-708-5p Enhances Erlotinib/paclitaxel Efficacy and Overcomes Chemoresistance in Lung Cancer CellsDOI 10.21203/rs.3.rs-87253/v1
Select a neighboring publication to make it the new centre.